(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Single-Use Bioprocessing - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global single-use bioprocessing market was valued at US$19.8 billion in 2025 and is projected to reach US$47.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 13.4% during the forecast period. Market growth is supported by rising demand for biologics, vaccines, biosimilars, monoclonal antibodies, therapeutic proteins, and cell and gene therapies.
Biopharmaceutical manufacturers are increasing their adoption of single-use bioprocessing technologies to improve production flexibility, accelerate facility changeovers, reduce capital requirements, and limit cross-contamination risks. Disposable bioreactors, filtration assemblies, mixers, bags, tubing, connectors, and sensors are being deployed across upstream processing, downstream processing, purification, storage, transfer, and fill-finish operations.
Single-Use Bioprocessing Market Trends and Growth Drivers
Demand for agile and scalable biomanufacturing infrastructure remains a major market driver. Single-use platforms can reduce cleaning validation requirements and production downtime, making them particularly relevant to multi-product facilities, modular plants, small-batch manufacturing, and rapidly expanding contract development and manufacturing organizations (CDMOs).
Technological innovation is also strengthening the performance and reliability of single-use systems. Advances in automated bioreactors, high-efficiency filtration systems, disposable sensors, connectors, mixers, and integrated assemblies are improving process monitoring, data integrity, production consistency, and regulatory compliance. Integration with continuous bioprocessing, modular facilities, and digital manufacturing platforms is creating additional opportunities to improve yields and control operating costs.
Industry investment continues to address scale-up requirements, extractables and leachables, supply-chain resilience, material performance, and waste management. Demand for recyclable materials and more sustainable disposable solutions is expected to influence future product development and procurement strategies.
Leading Market Segments
The report analyzes the single-use bioprocessing market by component, molecule, application, end use, and geography. Component categories include equipment and consumables. The equipment segment is projected to reach US$27.6 billion by 2032, advancing at a CAGR of 11.6%, while the consumables segment is forecast to grow at a CAGR of 16.3% over the analysis period.
Components: Equipment and consumables. Molecules: Monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. Applications: Cell culture, filtration, purification, mixing, storage and transfer, and other bioprocessing applications. End users: Pharmaceutical and biotechnology companies, contract research organizations, contract manufacturing organizations, and other institutions.
Monoclonal antibody production represents a major application area due to sustained global demand for biologic medicines. Cell and gene therapy manufacturing is also supporting adoption, as developers require adaptable production platforms capable of handling complex workflows and variable batch sizes.
Regional Market Outlook
North America and Europe remain leading markets, supported by established biopharmaceutical infrastructure, significant research and development investment, advanced manufacturing capabilities, and favorable regulatory environments. The U.S. single-use bioprocessing market was valued at US$5.9 billion in 2025.
China is forecast to expand at a CAGR of 12.8% and reach US$8.2 billion by 2032. The broader Asia-Pacific region is positioned for substantial growth as biotechnology capacity expands and investment increases in biologics, vaccines, biosimilars, and advanced therapies. The geographic analysis also covers Canada, Japan, France, Germany, Italy, the United Kingdom, the rest of Europe, and the rest of the world.
Report Scope and Strategic Value
The report provides independent analysis of annual sales and market forecasts from 2025 through 2032, presented in US$ million. It evaluates competitive conditions, market opportunities, technology trends, adoption barriers, regional developments, and the strategic outlook for major product and application segments.
Detailed global and regional single-use bioprocessing market forecasts. Analysis of growth drivers, restraints, emerging technologies, and adoption trends. Assessment of equipment and consumables across major biopharmaceutical workflows. Competitive intelligence covering leading market participants and geographic presence. Actionable insights for identifying revenue opportunities and supporting investment decisions. Complimentary report updates for one year.
Companies Featured
3M Company Applikon Biotechnology BV Cesco Bioengineering Co. Ltd. Danaher Corporation Eppendorf AG GE Healthcare Thermo Fisher Scientific, Inc.
Domain Expert Insights
The analysis incorporates perspectives from domain experts across industry, enterprise, and academia. The report tracks early market signals emerging from expert discussions, company activity, conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications, and other validated sources.
These inputs are synthesized to identify strategic market direction, evolving competitive dynamics, and developments likely to influence biopharmaceutical manufacturing. The report also provides company-level intelligence and examines market share where it is most analytically relevant. Because competitive structures differ by geography, regional market share analysis is tailored to the characteristics and maturity of individual markets rather than relying exclusively on a single global measure.
Key Questions Addressed
How will the global single-use bioprocessing market evolve through 2032? Which technologies, applications, and end-user categories will generate the strongest growth? What factors are driving or restricting market adoption? How will regional and segment-level market shares change during the forecast period? Which companies are shaping the competitive landscape, and what are their growth prospects?
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment